Skip Navigation

FDA approves cure for sickle cell disease, the first treatment to use CRISPR

www.nbcnews.com FDA approves cure for sickle cell disease, the first treatment to use CRISPR

The groundbreaking approval has been eagerly anticipated by patients and doctors alike. The treatment is priced at $2.2 million per person.

FDA approves cure for sickle cell disease, the first treatment to use CRISPR
29
29 comments
You've viewed 29 comments.